Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen

Clinical and Experimental Immunology

Volumn 124, Issue 2, 2001, Pages 248-254

  Moss, R B ^a   Giermakowska, W K ^a   Wallace, M R ^b   Jensen, F C ^a   Maigetter, R Z ^a   Carlo, D J ^a  

^a Orchestra Therapeutics Inc   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

CD8; HIV 1; Immunogen; Perforin

Indexed keywords

EFAVIRENZ; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; PERFORIN; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AIDS VACCINES; ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HIV SEROPOSITIVITY; HIV-1; HUMANS; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 0034948660     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01534.x     Document Type: Article

References (20)

1. Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens
2. HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
3. Human immunodeficiency virus isolated from a serum sample collected in 1976 in Central Africa
4. HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant
5. Investigations of the use of beta-propiolactone in virus inactivation
6. Effect of gamma irradiation on the human immunodeficiency virus and human coagulation proteins
7. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
8. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry
9. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry
10. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A. Evidence for membrane cycling from Golgi to ER
11. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis
12. Effect of HAART on HIV-specific CTL and general immune reconstitution
13. CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: Loss of CASA is associated with loss of viremia
14. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
15. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)
16. Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy
17. Enhancement of HIV type 1 antigen-specific CD4+ T cell memory in subjects with chronic HIV type 1 infection receiving HIV type 1 immunogen
18. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection
19. Therapeutic vaccination against chronic viral infection: The importance of cooperation between CD4+ and CD8+ T cells